A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families

Familial Cancer

Volumn 6, Issue 4, 2007, Pages 491-497

  Tonin, Patricia N ^a,b,c   Maugard, Christine M ^d,e,f   Perret, Chantal ^d   Mes Masson, Anne Marie ^d,f   Provencher, Diane M ^d,e,f  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d NOTRE DAME HOSPITAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

BRCA1; BRCA2; French Canadian; Mucinous ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER FAMILY; FEMALE; GENE MUTATION; GERM LINE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MUTAGENESIS; MUTATIONAL ANALYSIS; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CANADA; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE;

EID: 35448938065     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9152-x     Document Type: Article

References (25)

1. Tonin PN et al (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63(5):1341-1351
2. Oros KK et al (2004) Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations. Int J Cancer 112(3):411-419
3. Oros KK et al (2006) Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. Clin Genet 70(4):320-329
4. Simard J et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8(4):392-398
5. Manning AP et al (2001) Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered 52(2):116-120
6. Vezina H et al (2005) Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families. Hum Genet 117(2-3):119-132
7. Oros KK et al (2006) Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families. BMC Med Genet 7(1):23
8. Scriver CR (2001) Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2:69-101
9. Laberge AM et al (2005) Population history and its impact on medical genetics in Quebec. Clin Genet 68(4):287-301
10. Miki Y et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66-71
11. Wooster R et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789-792
12. Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898-5905
13. Ford D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676-689
14. Liede A et al (1998) Is hereditary site-specific ovarian cancer a distinct genetic condition? Am J Med Genet 75(1):55-58
15. Walsh T et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. Jama 295(12):1379-1388
16. Smith P et al (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45(7):646-655
17. Antoniou AC et al (2006) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8(1):R3
18. Simard J et al (2006) Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multi-step testing approach in French-Canadian high-risk breast and ovarian cancer families. J Med Genet 44(2):107-121
19. Moisan AM et al (2006) No evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. Genet Test 10(2):104-115
20. Lee JS et al (2006) Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Cancer Epidemiol Biomarkers Prev 15(2):359-363
21. Prat J, Ribe A, Gallardo A (2005) Hereditary ovarian cancer. Hum Pathol 36(8):861-870
22. Canada C.C.S.N.C.I.o (2006) Canadian cancer statistic 2006. Toronto, Canada
23. Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351(24):2519-2529
24. Godard B et al (1998) Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study. Am J Obstet Gynecol 179(2):403-410
25. Tonin PM et al (1999) Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history. Clin Genet 55(5):318-324